The Scientific and Technical Advisory team at Atalanta Therapeutics provides expert guidance and strategic oversight on the development of innovative RNA interference therapies targeting neurodegenerative diseases. Comprising experienced co-founders and directors, this team collaborates to assess scientific advancements, shape research directions, and ensure alignment with the company’s mission to deliver effective treatment options.
View all